MORPHOTEK, INC.
Patent Owner
Stats
- 62 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Mar 13, 2018 most recent publication
Details
- 62 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 990 Total Citation Count
- Nov 07, 2000 Earliest Filing
- 36 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9650440 Monoclonal antibodies that specifically block biological activity of a tumor antigenMar 14, 13May 16, 17[A61K, C07K]
9637526 Chlorotoxin polypeptides and conjugates and uses thereofDec 01, 15May 02, 17[A61K, G01N, C07K]
9624297 Monoclonal antibodies that specifically block biological activity of a tumor antigenJul 09, 09Apr 18, 17[A61K, C07K]
9522195 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cellsJul 27, 15Dec 20, 16[A61K, B82Y, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0212,410 CO-ADMINISTRATION OF ERIBULIN AND FARLETUZUMAB FOR THE TREATMENT OF BREAST CANCERAbandonedMar 02, 13Jul 31, 14[A61K]
2012/0207,771 FOLATE RECEPTOR ALPHA AS A DIAGNOSTIC AND PROGNOSTIC MARKER FOR FOLATE RECEPTOR ALPHA-EXPRESSING CANCERSAbandonedNov 04, 11Aug 16, 12[A61K, G01N, A61P]
2012/0164,137 ANTI-FOLATE RECEPTOR ALPHA ANTIBODY GLYCOFORMSAbandonedOct 19, 11Jun 28, 12[A61K, C12P, C12N, G01N, A61P, C07K]
2011/0311,445 DIAGNOSIS AND TREATMENT OF MYELOID AND LYMPHOID CELL CANCERSAbandonedMay 09, 11Dec 22, 11[A61K, G01N, A61P]
2010/0260,769 ENDOSIALIN BINDING MOLECULESAbandonedApr 08, 10Oct 14, 10[A61K, C12P, C12N, G01N, A61P, C07K]
2010/0215,575 Systemic Administration of Chlorotoxin Agents for the Diagnosis and Treatment of TumorsAbandonedOct 10, 08Aug 26, 10[A61K, A61P]
2010/0021,996 Genetically Altered Anti-body Producing Cell Lines With Improved Antibody CharacteristicsAbandonedSep 24, 09Jan 28, 10[C12N]
7604994 Genetically altered antibody-producing cell lines with improved antibody characteristicsExpiredSep 02, 04Oct 20, 09[C12N]
2008/0153,746 Diagnosis and Treatment of Myeloid and Lymphoid Cell CancersAbandonedApr 06, 05Jun 26, 08[A61K, G01N, A61P]
2008/0131,427 Whole Genome Evolution Technology Applied To Improve Protein And Antibody Yields By CellsAbandonedApr 16, 07Jun 05, 08[A61K, C12N]
2007/0275,902 Treatment of Phosphatidylinositol Phospholipid DisordersAbandonedNov 23, 04Nov 29, 07[A61K, C12N, G01N, A61P]
2007/0065,904 Recombinant expression vectors for functional nav1.9 sodium channelsAbandonedMar 20, 03Mar 22, 07[C07H, C12N, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.